- Home
- GT vs SLNO Comparison
GT vs SLNO Comparison
Compare GT & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GT
- SLNO
- Stock Information
- Founded
- GT 1898
- SLNO 1999
- Country
- GT United States
- SLNO United States
- Employees
- GT N/A
- SLNO N/A
- Industry
- GT Automotive Aftermarket
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- GT Consumer Discretionary
- SLNO Health Care
- Exchange
- GT Nasdaq
- SLNO Nasdaq
- Market Cap
- GT 3.2B
- SLNO 3.2B
- IPO Year
- GT N/A
- SLNO 2014
- Fundamental
- Price
- GT $11.20
- SLNO $75.66
- Analyst Decision
- GT Buy
- SLNO Strong Buy
- Analyst Count
- GT 3
- SLNO 9
- Target Price
- GT $14.67
- SLNO $103.33
- AVG Volume (30 Days)
- GT 6.2M
- SLNO 751.6K
- Earning Date
- GT 05-07-2025
- SLNO 05-07-2025
- Dividend Yield
- GT N/A
- SLNO N/A
- EPS Growth
- GT N/A
- SLNO N/A
- EPS
- GT 0.84
- SLNO N/A
- Revenue
- GT $18,594,000,000.00
- SLNO N/A
- Revenue This Year
- GT $0.10
- SLNO N/A
- Revenue Next Year
- GT $1.14
- SLNO N/A
- P/E Ratio
- GT $13.33
- SLNO N/A
- Revenue Growth
- GT N/A
- SLNO N/A
- 52 Week Low
- GT $7.27
- SLNO $36.93
- 52 Week High
- GT $12.58
- SLNO $80.99
- Technical
- Relative Strength Index (RSI)
- GT 55.37
- SLNO 55.95
- Support Level
- GT $10.38
- SLNO $72.59
- Resistance Level
- GT $11.69
- SLNO $78.32
- Average True Range (ATR)
- GT 0.39
- SLNO 2.75
- MACD
- GT -0.01
- SLNO -0.49
- Stochastic Oscillator
- GT 62.60
- SLNO 62.72
About GT The Goodyear Tire & Rubber Company
Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment. The company operates its business through three operating segments representing its regional tire businesses: Americas; Europe, the Middle East, and Africa (EMEA); and the Asia Pacific.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.